The Advanced Therapy CDMO market is a subset of the genomics industry that focuses on the development and manufacturing of cell and gene therapies. These therapies are used to treat a variety of diseases, including cancer, neurological disorders, and rare genetic diseases. Advanced Therapy CDMOs provide services such as process development, analytical testing, and clinical and commercial manufacturing. They also provide support for regulatory filings and clinical trials. Advanced Therapy CDMOs are an important part of the genomics industry, as they enable the development and commercialization of novel therapies. They provide the necessary infrastructure and expertise to bring these therapies to market. Some companies in the Advanced Therapy CDMO market include Lonza, Thermo Fisher Scientific, Catalent, and Fujifilm Diosynth Biotechnologies. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
